TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	19.6	3.67	14.25
Cash & Short-Term Investments	19.6	3.67	14.25
Cash Growth	-	-74.29%	-
Receivables	0.36	-	0.1
Other Current Assets	6.77	0.49	0.39
Total Current Assets	26.72	4.16	14.74
Property, Plant & Equipment	0.36	0.2	0.42
Other Long-Term Assets	0.03	-	0.03
Total Assets	27.11	4.36	15.2
Accounts Payable	1.33	1.87	1.92
Accrued Expenses	1.09	1.57	0.84
Current Portion of Leases	0.16	0.02	0.12
Other Current Liabilities	2.85	0.14	-
Total Current Liabilities	5.43	3.6	2.87
Long-Term Debt	24.37	2.32	-
Long-Term Leases	0.08	-	0.02
Total Liabilities	29.88	5.92	2.89
Common Stock	0.01	0.01	0
Additional Paid-In Capital	102.34	86.9	71.45
Retained Earnings	-105.13	-88.47	-59.16
Total Common Equity	-2.78	-1.57	12.3
Shareholders' Equity	-2.77	-1.56	12.3
Total Liabilities & Equity	27.11	4.36	15.2
Total Debt	24.61	2.34	0.14
Net Cash (Debt)	-5.01	1.32	14.11
Net Cash Growth	-	-90.65%	-
Net Cash Per Share	-0.07	0.02	-
Filing Date Shares Outstanding	76.37	68.01	-
Total Common Shares Outstanding	76.37	68.01	-
Working Capital	21.29	0.56	11.87
Book Value Per Share	-0.04	-0.02	-
Tangible Book Value	-2.78	-1.57	12.3
Tangible Book Value Per Share	-0.04	-0.02	-
Machinery	1.57	1.54	1.5
Leasehold Improvements	0.54	0.54	0.54

Source: S&P Capital IQ. Standard template. Financial Sources.